Description
DRUGS AND SUPPLIES
First action · last action
2014-12-18 · 2014-12-18
Transactions
1
First transaction's obligation
$19,451
Base + all options value (sum of deltas)
$19,451
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-12-18+$19,451= $19,451
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-12-18 | +$19,451 | $19,451 | DRUGS AND SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EP32BZ8XN3A2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26123P0628 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $14,221 | FY2023 |
| 36C26123P0590 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C26123P0479 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26123P0366 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26123P0086 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26122P1803 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2022 |
Other recipients under 6505 from 603-LOUISVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24916J2015 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 603-LOUISVILLE | $3,081 | FY2016 |
| VA24916J1966 | GRIFOLS THERAPEUTICS LLC | 603-LOUISVILLE | $4,596 | FY2016 |
| VA24916J1860 | GRIFOLS THERAPEUTICS LLC | 603-LOUISVILLE | $22,627 | FY2016 |
| VA24916J1713 | ACTELION PHARMACEUTICALS US, INC. | 603-LOUISVILLE | $6,438 | FY2016 |
| VA24916P1594 | MCKESSON PLASMA AND BIOLOGICS LLC | 603-LOUISVILLE | $4,615 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24915P0902_3600_-NONE-_-NONE- · retrieved 2026-09-26.